Hydroxylamine, H2N-OH, and its hydrocarbyl derivatives.
ChEBI ID: 24709
| Member | Definition | Role |
|---|---|---|
| 2-amino-n(6)-hydroxyadenine | A 2,6-diaminopurine that is the N(6)-hydroxy derivative of 2,6-diamino-3H-purine. | 2-amino-6-hydroxyaminopurine |
| 6-n-hydroxylaminopurine | A member of the class of 6-aminopurinnes that is adenine in which one of the exocyclic amino hydrogens is replaced by a hydroxy group. | N(6)-hydroxyadenine |
| aminooxyacetic acid | A member of the class of hydroxylamines that is acetic acid substituted at postion 2 by an aminooxy group. It is a compound which inhibits aminobutyrate aminotransferase activity in vivo, resulting in increased levels of gamma-aminobutyric acid in tissues. | (aminooxy)acetic acid |
| aurachin c | A C-type aurachin that is quinolin-4-one which is substituted by a hydroxy group at positions 1, a methyl group at position 2, and a triprenyl group at position 3. | aurachin C |
| delta-n-hydroxyornithine | A member of the class of hydroxylamines that is L-ornithine in which one of the N(5)-amino hydrogens is replaced by a hydroxy group. | N(5)-hydroxy-L-ornithine zwitterion; N(5)-hydroxy-L-ornithine |
| hydroxylamine | The simplest hydroxylamine, consisting of ammonia bearing a hydroxy substituent. It is an intermediate in the biological nitrification by microbes like bacteria. | hydroxylamine |
| procainamide 4-hydroxylamine | A benzamide obtained via formal condensation of 4-hydroxylaminobenzoic acid and 2-(diethylamino)ethylamine; a metabolite in liver microsomes. | procainamide 4-hydroxylamine |
| ximelagatran | A member of the class of azetidines that is melagatran in which the carboxylic acid group has been converted into the corresponding ethyl ester and in which the amidine group has been converted to the corresponding hydroxylamine. Tautomeric with the oxime form of ximelagatran. | ximelagatran (hydroxylamine form); ximelagatran |
| Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
|---|---|---|
| pre-1990 | 933 (31.55) | 18.7374 |
| 1990's | 686 (23.20) | 18.2507 |
| 2000's | 751 (25.40) | 29.6817 |
| 2010's | 501 (16.94) | 24.3611 |
| 2020's | 86 (2.91) | 2.80 |
| Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
|---|---|---|
| Trials | 82 (2.65%) | 5.53% |
| Reviews | 233 (7.53%) | 6.00% |
| Case Studies | 9 (0.29%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 2,771 (89.53%) | 84.16% |